Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.
Roehrig A, Hirsch TZ, Pire A, Morcrette G, Gupta B, Marcaillou C, Imbeaud S, Chardot C, Gonzales E, Jacquemin E, Sekiguchi M, Takita J, Nagae G, Hiyama E, Guérin F, Fabre M, Aerts I, Taque S, Laithier V, Branchereau S, Guettier C, Brugières L, Fresneau B, Zucman-Rossi J, Letouzé E. Roehrig A, et al. Among authors: hiyama e. Nat Commun. 2024 Apr 8;15(1):3031. doi: 10.1038/s41467-024-47280-x. Nat Commun. 2024. PMID: 38589411 Free PMC article.
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution.
O'Neill AF, Trobaugh-Lotrario A, Geller JI, Hiyama E, Watanabe K, Aerts I, Fresneau B, Toutain F, Sullivan MJ, Katzenstein HM, Morland B, Branchereau S, Zsiros J, Maibach R, Ansari M. O'Neill AF, et al. Among authors: hiyama e. EClinicalMedicine. 2024 Feb 15;69:102446. doi: 10.1016/j.eclinm.2024.102446. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384339 Free PMC article. Review.
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
Pire A, Hirsch TZ, Morcrette G, Imbeaud S, Gupta B, Pilet J, Cornet M, Fabre M, Guettier C, Branchereau S, Brugières L, Guerin F, Laithier V, Coze C, Nagae G, Hiyama E, Laurent-Puig P, Rebouissou S, Sarnacki S, Chardot C, Capito C, Faure-Conter C, Aerts I, Taque S, Fresneau B, Zucman-Rossi J. Pire A, et al. Among authors: hiyama e. Eur J Cancer. 2024 Mar;200:113583. doi: 10.1016/j.ejca.2024.113583. Epub 2024 Feb 1. Eur J Cancer. 2024. PMID: 38330765 Free article.
Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature.
Trobaugh-Lotrario A, Watanabe K, O'Neill AF, Dembowska-Bagińska B, Häberle B, Murphy A, Hiyama E, Czauderna P, Meyers RL, Langham M, Feusner J. Trobaugh-Lotrario A, et al. Among authors: hiyama e. J Pediatr Hematol Oncol. 2024 Mar 1;46(2):80-87. doi: 10.1097/MPH.0000000000002824. Epub 2024 Feb 2. J Pediatr Hematol Oncol. 2024. PMID: 38316145 Review.
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study.
Fukushima T, Goto K, Hayashi T, Ikeda K, Hatayama T, Yamanaka R, Iwane K, Tasaka R, Kohada Y, Takemoto K, Kobatake K, Goriki A, Toshida A, Nakahara H, Motonaga M, Tokumo K, Fujii Y, Hayes CN, Okamoto W, Kubo T, Matsumoto T, Shiota M, Yamamoto N, Urabe Y, Hiyama E, Arihiro K, Hinoi T, Hinata N. Fukushima T, et al. Among authors: hiyama e. Jpn J Clin Oncol. 2024 Feb 7;54(2):175-181. doi: 10.1093/jjco/hyad148. Jpn J Clin Oncol. 2024. PMID: 37899139
255 results